Open AccessStatins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients
Author(s) -
Eryka Karbowska,
Damian Świeczkowski,
Aleksandra Gąsecka,
Michał Pruc,
Kamil Safiejko,
Jerzy Robert Ładny,
Tomasz Kopiec,
Miłosz Jaguszewski,
Krzysztof J. Filipiak,
Zubaid Rafique,
Łukasz Szarpak
Publication year - 2022
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2022.0014
Subject(s) - medicine , meta analysis , statin , pancreatic cancer , subgroup analysis , odds ratio , confidence interval , randomized controlled trial , relative risk , cancer , oncology
Statin use in many studies is related to the improvement of a patients' condition including reducing the risk of various malignancies. Herein, is a systematic review and meta-analysis to examine the evidence on the association between statin therapy and the risk of the occurrence of pancreatic cancer, mainly in terms of decreased risk of developing pancreatic cancer among patients using statin therapy in the long-term perspective.